FDA decision on Jazz Pharmaceuticals narcolepsy drug expected Wednesday
March 19, 2019 at 11:09 AM EDT
Jazz is seeking approval for solriamfetol for both excessive sleepiness in adult patients with narcolepsy and obstructive sleep apnea.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|